• Upstream 

We use scientifically sound techniques and statistically meaningful analysis to reach optimal titer values and generate superior quality products using mammalian cell culture platform. Every step is geared towards developing a fully compliant, efficient, scale up manufacturing process. 

• Downstream

The purification process development team utilizes widespread industry knowledge from small to large scale culture media to optimize higher titers, identify areas of improvement for scale-up, and minimize potential risks during tech transfer processes.

• Analytics

Our assay analytical expertise makes us capable of efficient method development and optimization of wide range of analytical methods used for in-process / release testing and for extended product characterizations throughout the biosimilar process development and characterization.

Here's also a list of capabilities throughout the process development activities:

• Experienced experts dedicated to development and support of early phase projects
• Formulations development and stability expertise
• Rapid optimization enabled by Design of Experiments (DOE)
• Development and scale up of PEGylation using various technologies